Hypercalcemia clinical trials
The registry lists 51 studies for Hypercalcemia across more than 10 countries. 9 are recruiting or about to start. 8 of them are mainly about Hypercalcemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Hypercalcemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Amgen (3) · Martin Blomberg Jensen (3) · Columbia University (2) · University Hospital, Caen (2) · Alberta Health services (1) · Soroka University Medical Center (1) · Kyowa Kirin Co., Ltd. (1)
What is being tested here
Drugs under test in Hypercalcemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Jan 2027Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil · Herlev Hospital
Who these studies take
Of the 8 Hypercalcemia studies recruiting now, 4 (50%) set no upper age limit and 2 (25%) stop at 75 or younger. 1 (13%) take children under 18. 0 (0%) are for women only and 2 (25%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (13%) | 1 (13%) |
| 18 | 6 (75%) | 8 (100%) |
| 30 | 6 (75%) | 8 (100%) |
| 40 | 6 (75%) | 8 (100%) |
| 50 | 6 (75%) | 8 (100%) |
| 65 | 6 (75%) | 8 (100%) |
| 75 | 5 (63%) | 6 (75%) |
| 85 | 5 (63%) | 5 (63%) |
Across all 51 studies, recruiting or not: 22% stop at 75 or younger and 10% at 65; 20% take children; 6% are for women only and 4% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
- The GranStone TrialNov 10, 2026NCT07828002
Studies
Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 → or search them.
- The GranStone TrialRecruitingNCT07828002Phase 2/31 country
- Rifampin in CYP24A1-related Hypercalcemia and HypercalciuriaRecruitingNCT03301038Phase 21 country
- Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine DisordersRecruitingNCT078241021 country
- Vitamin D Analog in Vitamin D 24-hydroxylase DeficiencyRecruitingNCT04987073Not applicable1 country
- Hypercalcemia After Paraffin Oil InjectionRecruitingNCT042922881 country
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableEnrolling by invitationNCT067635491 country
- Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of ParaffinoilRecruitingNCT042655991 country
- Calcitonin Pre-treatment to Improve SPECT-CT SensitivityRecruitingNCT03935984Phase 41 country
- Registry for Hypoparathyroidism WuerzburgRecruitingNCT055855931 country
- Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT05152927Not applicable1 country
- Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT05022641Not applicable1 country
- Vitamin D In the Prevention of Viral-induced Asthma in PreschoolersCompletedNCT03365687Phase 31 country
- Cinacalcet to Treat Hypercalcemia in Renal Transplant RecipientsTerminatedNCT00415584Phase 1/21 country
- Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German HospitalActive, not recruitingNCT064678771 country
- The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid RegistryCompletedNCT014097981 country
- Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT04299425Not applicable1 country
- Familial Hypocalciuric Hypercalcemia: Clinical Aspects and EvolutionCompletedNCT048728941 country
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. ParicalcitolTerminatedNCT01725113Phase 41 country
- Does Treatment of Hypovitaminosis D Increase Calcium Absorption?CompletedNCT00581828Phase 41 country
- Studies of Inherited Diseases of MetabolismCompletedNCT000013451 country
- Studies of Elevated Parathyroid ActivityCompletedNCT00001277Phase 21 country
- Preoperational Fine Needle Aspiration of Pathological Parathyroid GlandWithdrawnNCT03516747Not applicable1 country
- Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum ElectrolytesCompletedNCT042563691 country
- The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIHStatus unknownNCT03384121Phase 11 country
- Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes PanelCompletedNCT029085421 country
- Insulin Resistance in Primary HyperparathyroidismWithdrawnNCT02711059Not applicable1 country
- Metabolic Workup in Patients Suffering From Kidney Stone Disease and OsteopeniaStatus unknownNCT04080973Not applicable1 country
- Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple MyelomaCompletedNCT01447914Phase 21 country
- Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumCompletedNCT00896454Phase 25 countries
- Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsCompletedNCT00975000Phase 311 countries
- Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo ParathyroidectomyCompletedNCT00975221Phase 37 countries
- Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis PatientsCompletedNCT00485706Not applicable1 country
- Cinacalcet to Treat Familial Primary HyperparathyroidismCompletedNCT00325104Phase 31 country
- An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary HyperparathyroidismCompletedNCT01460030Phase 31 country
- Vitamin D Supplementation in Older WomenCompletedNCT00472823Not applicable1 country
- Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.CompletedNCT00744302Phase 21 country
- Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal TransplantationCompletedNCT01178450Phase 41 country
- Efficacy of Cinacalcet in the Control of Primary HyperparathyroidismCompletedNCT02417389Phase 41 country
- Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin DWithdrawnNCT01329666Phase 2/31 country
- ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot StudyStatus unknownNCT02155803Phase 2/31 country
- Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)CompletedNCT00823303Phase 41 country
- Differentially Expressed Proteins in Sporadic Parathyroid TumorsStatus unknownNCT016475031 country
- Effect of Vitamin D Treatment in Primary HyperparathyroidismCompletedNCT00674154Phase 2/31 country
- Parathyroid Hormone (PTH) Homeostasis in Bartter SyndromeStatus unknownNCT010212801 country
- Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the CommunityCompletedNCT00126386Not applicable1 country
- The Effects of Alendronate After Cure of Primary HyperparathyroidismWithdrawnNCT00359385Phase 41 country
- Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial DoseCompletedNCT00891813Phase 41 country
- The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to ExplorationStatus unknownNCT012268101 country
- Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy SubjectsCompletedNCT01042626Not applicable1 country
- Initial Dosing of Paricalcitol in Secondary HyperparathyroidismCompletedNCT00307840Phase 4